Immunodiagnostic Systems upbeat on half year sales performance
Immunodiagnostic Systems Hldgs (LON:IDH), the company that produces diagnostic testing kits for the clinical and research markets, this morning reported that year-on-year sales in the first six months of the year were up 34% at £22.6m and 11% ahead of the second half of 2009 on a like for like basis.
In a trading update ahead of its interim results to September 30, which are due to be published on November 30, IDH said it had made continued progress in placing instruments into reagent rental accounts as well as outright unit sales. At the end of September the group had sold or placed 140 iSYS machines since launch in February 2009, almost doubling the number of machines in the market at the previous financial year in March. IDH added that overall trading remained in line with management expectations and it was confident going forward that it would continue to execute its plans for the current year.
Shares in IDH reached a 12 month high of 920.5p yesterday. Earlier this summer outgoing chief executive Roger Duggan spoke to Stockopedia about the “astonishing” trajectory of the company’s stock this year.
Filed Under: Medical Equipment,
but do you know where to look?
Get the most concise synopsis of everything that's been proven to work in value investing. If you like your stocks cheap you've found a treasure trove distilled to under 70 pages.
- How to find ultimate Bargain Stocks with Ben Graham
- How to spot Turnarounds and avoid Value Traps
- From Graham to Greenblatt via Piotroski & Lakonishok
- How to value stocks and set a margin of safety
Disclaimer:
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Immunodiagnostic Systems Holdings plc (IDS) is engaged in manufacturing and distributing medical diagnostic products. The Company is also involved in research and development projects. The Company’s main operation is within the in vitro diagnostic (IVD) testing industry, supplying test kits to hospital and research laboratories. The Company is also engaged in the provision of immunoassay tests for the determination of vitamin D (both 25-Hydroxy and 1,25-Dihydroxy). The Company’s product include 1,25-Dihydroxy Vitamin D EIA, 1,25-Dihydroxy Vitamin D RIA, 25-Hydroxy Vitamin D EIA, 25-Hydroxy Vitamin D RIA ,Alpha CrossLaps (CTX-I) EIA, Automated IDS-iSYS System, BoneTRAP (TRAcP 5b) ELISA, Corticosterone EIA, Corticosterone HS EIA and CrossLaps for Culture (CTX-I) ELISA. more »
